Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.

Literature DB >> 2158340

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.

P Marino¹, M Cugno, A Preatoni, P Cori, A Rosti, L Frontini, M Cicardi.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
Receptors, Interleukin-2

Year: 1990 PMID： 2158340 PMCID： PMC1971291 DOI： 10.1038/bjc.1990.95

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

12 in total

Review 1. Interleukins and the immune system 1.

Authors: A O'Garra
Journal: Lancet Date: 1989-04-29 Impact factor: 79.321

Review 2. The interleukins in acquired disease.

Authors: M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal: Clin Exp Immunol Date: 1988-11 Impact factor: 4.330

Review 3. The soluble interleukin-2 receptor in haematological disorders.

Authors: G Pizzolo; M Chilosi; G Semenzato
Journal: Br J Haematol Date: 1987-12 Impact factor: 6.998

4. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors: T Uchiyama; S Broder; T A Waldmann
Journal: J Immunol Date: 1981-04 Impact factor: 5.422

5. Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS.

Authors: B E Kloster; P A John; L E Miller; L A Rubin; D L Nelson; D C Blair; R H Tomar
Journal: Clin Immunol Immunopathol Date: 1987-12

6. Plasma interleukin 2 receptor levels in renal allograft recipients.

Authors: R B Colvin; T C Fuller; L MacKeen; P C Kung; S H Ip; A B Cosimi
Journal: Clin Immunol Immunopathol Date: 1987-05

7. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors: S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal: N Engl J Med Date: 1987-04-09 Impact factor: 91.245

3. Effect of heavy-ion beam irradiation on the level of serum soluble interleukin-2 receptors in hamster cheek pouch carcinoma model.

Authors: Xiaoli An; Mingxin Li; Na Li; Bin Liu; Hong Zhang; Jizeng Wang
Journal: Biomed Rep Date: 2014-02-17

3 in total

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.

Review 1. Interleukins and the immune system 1.

Review 2. The interleukins in acquired disease.

Review 3. The soluble interleukin-2 receptor in haematological disorders.

4. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

5. Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS.

6. Plasma interleukin 2 receptor levels in renal allograft recipients.

7. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

8. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

Review 9. The clinical potential of interleukin-2.

10. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.

1. Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection.

2. Biological significance of soluble IL-2 receptor.

3. Effect of heavy-ion beam irradiation on the level of serum soluble interleukin-2 receptors in hamster cheek pouch carcinoma model.